Rh
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-66.9% vs price
Base Case (Median)
-17.8% vs price
Bull Case (75th pct.)
41.8% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $-544.92 | -409.8% | High (40%) |
| PE Comparable | $97.22 | -44.7% | Medium (25%) |
| Growth Trajectory DCF | $263.10 | 49.6% | Medium (20%) |
| Graham Number | $19.41 | -89.0% | Medium (30%) |
| EV/EBITDA | $288.38 | 63.9% | Medium (20%) |
| EV/FCF | $235.60 | 33.9% | Medium (20%) |
| Earnings Power Value | $144.58 | -17.8% | Medium (50%) |
Based on 7 out of 8 methods, RH appears fairly valued at the current price of $175.90. The base case fair value of $144.58 implies 17.8% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.